Nifty

:

24414.40

Sensex

:

80746.78

34.80 (0.14%)
105.71 (0.13%)

Login

Nifty
Sensex

:
:

24414.40
80746.78

34.80 (0.14%)
105.71 (0.13%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

98.03

06-Feb-2025

Open
High
Low
Previous Close

100.00
100.00
97.01
100.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4149
4.14
129.07
61.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

163.54
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

367.96
N/A
-1.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
8.58
-5.48

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.95
-14.00
-23.81

PAT CAGR (%)

10 Years
5 Years
3 Years

9.67
-7.33
-23.76

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-4.35
-4.29
-1.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-25.57
-23.20
-27.35

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 11.47 12.98 -11.63% 12.86 14.89 -13.63% 12.89 10.58 21.83% 11.97 11.46 4.45%
Expenses 16.18 15.07 7.37% 15.57 15.79 -1.39% 15.08 13.20 14.24% 15.09 16.09 -6.22%
EBITDA -4.72 -2.09 - -2.71 -0.90 - -2.20 -2.62 - -3.11 -4.62 -
EBIDTM -41.13% -16.11% -21.08% -6.05% -17.05% -24.76% -26.01% -40.35%
Other Income 0.25 0.03 733.33% 0.09 0.17 -47.06% 0.03 0.04 -25.00% 0.21 0.19 10.53%
Interest 1.56 1.19 31.09% 1.43 1.13 26.55% 1.32 1.10 20.00% 1.27 1.03 23.30%
Depreciation 1.72 1.73 -0.58% 1.71 1.71 0.00% 1.69 1.65 2.42% 1.67 1.48 12.84%
PBT -7.74 -4.98 - -5.76 -3.57 - -5.17 -5.33 - -5.85 -6.94 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -7.74 -4.98 - -5.76 -3.57 - -5.17 -5.33 - -5.85 -6.94 -
PATM -67.49% -38.36% -44.82% -23.99% -40.12% -50.39% -48.84% -60.54%
EPS -3.58 -2.30 - -2.67 -1.65 - -2.39 -2.47 - -2.71 -3.21 -

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 49.19 50.42 52.13 59.70 53.70 33.41 47.76 33.78 3.53 1.29 0.00 Net Sales Growth -1.44% -3.28% -12.68% 11.17% 60.73% -30.05% 41.39% 856.94% 173.64% 0 Cost Of Goods Sold 7.88 6.59 25.68 40.64 25.94 15.86 23.10 12.67 1.20 0.14 0.00 Gross Profit 41.31 43.83 26.46 19.06 27.75 17.55 24.65 21.10 2.33 1.14 0.00 GP Margin 83.97% 86.93% 50.76% 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% 88.37% 0 Total Expenditure 61.92 59.15 67.91 93.70 71.28 51.97 57.52 41.28 11.53 13.69 4.90 Power & Fuel Cost - 22.01 14.80 22.23 15.91 10.28 11.70 8.62 0.70 2.87 0.28 % Of Sales - 43.65% 28.39% 37.24% 29.63% 30.77% 24.50% 25.52% 19.83% 222.48% 0 Employee Cost - 16.17 15.54 14.96 15.30 14.56 14.41 11.49 5.63 5.67 1.86 % Of Sales - 32.07% 29.81% 25.06% 28.49% 43.58% 30.17% 34.01% 159.49% 439.53% 0 Manufacturing Exp. - 11.25 8.48 11.11 10.37 6.77 4.09 4.59 1.07 1.62 0.62 % Of Sales - 22.31% 16.27% 18.61% 19.31% 20.26% 8.56% 13.59% 30.31% 125.58% 0 General & Admin Exp. - 3.03 3.25 4.47 3.47 4.05 4.05 3.76 2.88 3.33 2.14 % Of Sales - 6.01% 6.23% 7.49% 6.46% 12.12% 8.48% 11.13% 81.59% 258.14% 0 Selling & Distn. Exp. - 0.09 0.16 0.27 0.14 0.16 0.13 0.13 0.05 0.04 0.00 % Of Sales - 0.18% 0.31% 0.45% 0.26% 0.48% 0.27% 0.38% 1.42% 3.10% 0 Miscellaneous Exp. - 0.00 0.00 0.00 0.13 0.29 0.02 0.02 0.01 0.02 0.00 % Of Sales - 0% 0% 0% 0.24% 0.87% 0.04% 0.06% 0.28% 1.55% 0 EBITDA -12.74 -8.73 -15.78 -34.00 -17.58 -18.56 -9.76 -7.50 -8.00 -12.40 -4.90 EBITDA Margin -25.90% -17.31% -30.27% -56.95% -32.74% -55.55% -20.44% -22.20% -226.63% -961.24% 0 Other Income 0.58 0.45 0.62 1.16 0.62 0.37 0.33 0.21 0.08 1.03 0.01 Interest 5.58 4.69 2.97 5.39 6.28 6.00 6.29 5.17 3.49 0.74 4.03 Depreciation 6.79 6.77 6.56 6.30 5.12 4.68 4.40 4.15 4.23 4.49 1.87 PBT -24.52 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -15.65 -16.60 -10.79 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -24.52 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 PAT before Minority Interest -24.52 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -49.85% -39.13% -47.36% -74.59% -52.81% -86.41% -41.90% -52.75% -454.67% -1265.12% 0 PAT Growth 0.00% - - - - - - - - - EPS -11.35 -9.13 -11.43 -20.62 -13.13 -13.37 -9.26 -8.25 -7.43 -7.56 -3.63

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds -119.22 -99.46 -75.09 -42.73 -25.00 -14.29 -17.78 1.48 13.01 18.28 Share Capital 21.56 21.56 21.56 19.62 18.00 16.63 13.74 13.74 13.06 9.51 Total Reserves -140.78 -121.02 -96.65 -66.52 -50.65 -30.92 -31.52 -12.27 -3.72 -14.08 Non-Current Liabilities 235.56 225.34 186.83 153.76 115.66 101.79 101.37 88.88 73.88 60.12 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 1.89 5.03 21.40 14.00 Unsecured Loans 183.50 173.25 132.93 100.55 65.51 50.23 49.78 37.76 3.91 43.61 Long Term Provisions 3.05 2.60 2.63 2.56 2.46 4.04 3.68 2.82 3.57 3.83 Current Liabilities 61.83 49.10 78.06 48.19 43.13 54.86 42.28 31.72 29.52 28.72 Trade Payables 18.97 15.28 37.91 20.78 22.65 21.44 17.76 10.99 12.37 16.54 Other Current Liabilities 31.87 22.57 29.01 15.92 18.50 32.00 23.27 19.86 16.34 12.09 Short Term Borrowings 9.93 9.99 9.99 10.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 1.06 1.26 1.17 1.49 1.99 1.43 1.25 0.87 0.82 0.09 Total Liabilities 178.17 174.98 189.80 159.22 133.79 142.36 125.87 122.08 116.41 107.12 Net Block 149.96 147.31 138.71 117.93 105.29 101.27 100.77 102.17 93.10 50.98 Gross Block 312.46 303.04 287.95 260.88 243.11 234.41 229.51 226.55 213.24 166.84 Accumulated Depreciation 162.50 155.73 149.25 142.95 137.82 133.15 128.74 124.38 120.14 115.86 Non Current Assets 160.73 158.92 154.31 137.80 114.94 111.39 108.64 109.10 107.03 92.26 Capital Work in Progress 2.00 4.09 8.38 11.94 4.19 3.48 3.73 3.50 10.54 7.46 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 8.77 7.52 7.23 7.71 5.24 6.22 3.72 3.23 3.19 33.82 Other Non Current Assets 0.00 0.00 0.00 0.23 0.21 0.42 0.41 0.20 0.20 0.00 Current Assets 17.44 16.06 35.49 21.42 18.86 30.98 17.24 12.97 9.39 14.87 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.80 11.95 25.56 16.60 15.00 8.96 11.73 5.45 5.64 5.45 Sundry Debtors 1.90 0.53 0.88 0.30 0.20 2.91 0.32 1.59 0.03 0.37 Cash & Bank 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 Other Current Assets 5.60 0.65 0.59 0.47 3.49 1.78 4.77 5.81 3.46 2.74 Short Term Loans & Adv. 5.06 2.85 8.36 3.33 3.18 1.57 4.44 5.67 3.38 0.59 Net Current Assets -44.39 -33.04 -42.57 -26.77 -24.27 -23.88 -25.04 -18.74 -20.14 -13.86 Total Assets 178.17 174.98 189.80 159.22 133.80 142.37 125.88 122.07 116.42 107.13

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2.30 -24.71 -17.22 -14.57 -35.50 3.90 -6.19 -11.20 -15.26 -45.26 PBT -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -16.05 -16.60 -10.79 Adjustment 11.88 9.82 11.41 11.68 8.95 10.31 6.46 10.67 3.45 8.84 Changes in Working Capital 10.15 -9.84 15.90 2.11 -15.58 13.71 9.12 -2.33 -1.38 -39.28 Cash after chg. in Working capital 2.30 -24.71 -17.22 -14.57 -35.50 3.90 -1.02 -7.71 -14.53 -41.23 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 -5.17 -3.49 -0.74 -4.03 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.82 -12.64 -22.90 -22.55 -10.22 -4.32 -2.77 -4.70 -4.00 -2.92 Net Fixed Assets -7.33 -10.80 -23.51 -25.52 -9.41 -4.65 -3.19 -6.27 -49.48 -2.92 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -0.49 -1.84 0.61 2.97 -0.81 0.33 0.42 1.57 45.48 0.00 Cash from Financing Activity 5.56 37.34 39.51 37.66 28.58 17.32 9.26 15.75 13.22 54.13 Net Cash Inflow / Outflow 0.05 -0.01 -0.61 0.54 -17.14 16.90 0.30 -0.15 -6.04 5.95 Opening Cash & Equivalents 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 Closing Cash & Equivalent 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) -55.29 -46.13 -34.83 -23.91 -18.14 -8.59 -12.49 1.04 6.91 -4.63 ROA -11.17% -13.54% -25.51% -19.36% -20.91% -14.92% -14.38% -13.46% -14.60% -6.44% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -296.70% -683.34% 0.00% ROCE -18.99% -28.59% -57.38% -40.28% -56.96% -35.41% -28.95% -27.13% -25.38% -4.33% Fixed Asset Turnover 0.16 0.18 0.22 0.21 0.14 0.21 0.15 0.02 0.01 0.00 Receivable days 8.79 4.91 3.60 1.71 17.00 12.36 10.34 83.55 51.87 0.00 Inventory Days 78.69 131.30 128.88 107.38 130.87 79.07 92.84 573.34 1435.63 0.00 Payable days 948.90 378.02 263.51 305.42 148.85 123.16 120.44 290.43 338.13 1500.06 Cash Conversion Cycle -861.42 -241.81 -131.03 -196.34 -0.98 -31.73 -17.27 366.46 1149.37 -1500.06 Total Debt/Equity -1.62 -1.84 -1.91 -2.37 -2.03 -3.74 -3.16 32.19 3.27 -13.34 Interest Cover -3.21 -7.30 -7.26 -3.52 -3.81 -2.18 -2.45 -3.60 -21.09 -0.95

Top Investors:

sun pharmaceutical industries ltd

guttikonda rajasekhar

guttikonda vara lakshmi

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
4th Feb 2025, 14:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback